| 1 |
34997858 | Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway. | 2022 Feb |
5 |
| 2 |
35568074 | Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment. | 2022 Aug 1 |
1 |
| 3 |
33755971 | Anlotinib inhibits the progress of colorectal cancer cells by antagonizing VEGFR/JAK2/STAT3 axis. | 2021 Mar |
4 |
| 4 |
30755242 | Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells. | 2019 Feb 12 |
3 |